An Implantable Ultrasonically-Powered Micro-Light-Source (µLight) for Photodynamic Therapy

Area of Science:

• Biomedical Engineering
• Oncology
• Photomedicine

Background:

• Photodynamic therapy (PDT) offers targeted cancer treatment with fewer side effects than chemotherapy.
• Limited light penetration in tissues restricts PDT to superficial applications.
• Existing endoscopic methods require invasive procedures for deep tumor access.

Purpose of the Study:

• To introduce an ultrasonically powered implantable microlight source (μLight) for deep-seated tumor treatment.
• To demonstrate the feasibility of localized light delivery to tumors several centimeters deep.
• To evaluate the therapeutic potential of μLight in preclinical cancer models.

Main Methods:

• Development of mm-scale implantable microlight sources (μLight) with piezoelectric transducers and LEDs.
• Ultrasonic powering for wireless energy transfer to the implants deep within tissues.
• In vitro studies using HeLa cells and in vivo studies using 4T1-induced breast cancer in mice.
• Measurement of optical power output and light radiation dose delivered by μLight.

Main Results:

• μLight implants successfully delivered therapeutic light levels (0.048–6.5 mW/cm²) up to 10 cm deep.
• In vitro tests showed a 70% decrease in HeLa cell viability upon μLight irradiation.
• In vivo studies confirmed μLight's capability to deliver therapeutic doses to tumors in mice.
• Achieved cytotoxicity levels comparable to clinical external light sources.

Conclusions:

• Ultrasonically powered μLight is a viable technology for deep-seated tumor photodynamic therapy.
• This implantable system overcomes the challenge of limited light penetration in conventional PDT.
• μLight offers a promising new modality for localized cancer treatment with reduced systemic toxicity.